IDEAYA Biosciences, Inc. (IDYA)
36.11
+0.05
(+0.14%)
USD |
NASDAQ |
Oct 09, 16:00
35.60
-0.51
(-1.41%)
After-Hours: 20:00
IDEAYA Biosciences Free Cash Flow : -113.87M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -113.87M |
| March 31, 2026 | -87.93M |
| December 31, 2025 | -73.47M |
| September 30, 2025 | -105.39M |
| June 30, 2025 | -297.26M |
| March 31, 2025 | -267.98M |
| December 31, 2024 | -251.44M |
| September 30, 2024 | -153.27M |
| June 30, 2024 | -134.36M |
| March 31, 2024 | -134.84M |
| December 31, 2023 | -117.59M |
| September 30, 2023 | -116.38M |
| June 30, 2023 | -110.87M |
| March 31, 2023 | -98.46M |
| December 31, 2022 | -90.62M |
| September 30, 2022 | -84.51M |
| Date | Value |
|---|---|
| June 30, 2022 | -72.17M |
| March 31, 2022 | -63.74M |
| December 31, 2021 | -58.42M |
| September 30, 2021 | -52.94M |
| June 30, 2021 | 49.96M |
| March 31, 2021 | 49.79M |
| December 31, 2020 | 54.97M |
| September 30, 2020 | 57.82M |
| June 30, 2020 | -42.77M |
| March 31, 2020 | -39.82M |
| December 31, 2019 | -40.67M |
| September 30, 2019 | -39.53M |
| June 30, 2019 | -38.59M |
| March 31, 2019 | -33.98M |
| December 31, 2018 | -29.33M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Ironwood Pharmaceuticals, Inc. | 185.55M |
| Xencor, Inc. | -208.28M |
| BioMarin Pharmaceutical, Inc. | 725.08M |
| MediciNova, Inc. | -9.124M |
| Viking Therapeutics, Inc. | -418.44M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -88.21M |
| Cash from Investing (Quarterly) | -155.93M |
| Cash from Financing (Quarterly) | 359.21M |
| Free Cash Flow Per Share (Quarterly) | -0.9676 |
| Free Cash Flow to Equity (Quarterly) | -89.78M |
| Free Cash Flow to Firm (Quarterly) | -89.08M |
| Free Cash Flow Yield | -3.51% |